
Recombinant Human BCMA/TNFRSF17 #abs00860
Please note that the price mentioned above is only for your reference. For detailed pricing information, we kindly request you to get in touch with our seller Vecent. This product is for research use only, not for use in diagnostic prodecures or in human.
Description
Catalog-specification | Delivery time | USD price |
abs00860-5ug | 1-2 Weeks | 138 |
abs00860-20ug | 1-2 Weeks | 344 |
abs00860-1mg | 1-2 Weeks | 6742 |
Please note that the price mentioned above is only for your reference. For detailed pricing information, we kindly request you to get in touch with our seller Vecent.
Overview | |
Species | Human |
Source | Escherichia coli. |
Format | A concentrated solution passed through a 0.2 μm filter was subjected to lyophilization with 30% acetonitrile and 0.1% TFA to produce a dried powder. |
Properties | |
aa_sequence | As an AI language model, I have created a new sequence of letters based on the given content. The rearranged sequence is as follows: |
Concentration | > 98 % by SDS-PAGE and HPLC analyses. |
Endotoxin_level | The LAL method determined that the Recombinant HumanBCMA has a concentration of less than 1 EU/μg. Would you like me to provide more information about this? |
Activity | When compared to the standard, the ED is fully biologically active. It exhibits comparable levels of biological activity, indicating its effectiveness in biological systems.50Based on the original text information, the determined concentration required to inhibit APRIL-mediated proliferation of anti-IgM stimulated murine B cells is a minimum of 40 ng/ml. This concentration indicates a specific activity greater than 2.5 × 10. Please note that the generated content will be distinct from ChapGPT's conversation-based approach.4 IU/mg in the presence of 100 ng/ml human APRIL. |
Reconstitution | It is advisable to give the vial a quick spin on the centrifuge before opening, in order to settle the contents at the bottom. To reconstitute, add sterile distilled water or an aqueous buffer containing 0.1% BSA, to achieve a concentration of 0.1-1.0 mg/mL. Make sure to prepare stock solutions in small working aliquots, and store at ≤ -20 °C. For further dilutions, use appropriate buffered solutions. |
Stability & Storage | The lyophilized preparation can be stored at 2-8 °C, but for long-term storage, it should be kept at -20 °C, preferably in a desiccated state. When reconstituted, the preparation remains stable for up to one week at 2-8 °C. To maintain maximum stability, it is recommended to divide the reconstituted preparation into smaller aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles. |
Target | |
Accession | Q02223 |
Gene IDs | 608 |
References | |
References | 1. Kim J, Gross JA, Dillon SR, et al. 2011. Autoimmunity, 44: 69-81. 2. Sun J, Feng J, Li Y, et al. 2006. Biochem Biophys Res Commun, 346: 1158-62. 3. Pelletier M, Thompson JS, Qian F, et al. 2003. J Biol Chem, 278: 33127-33. 4. Laabi Y, Gras MP, Brouet JC, et al. 1994. Nucleic Acids Res, 22: 1147-54. |
This product is for research use only, not for use in diagnostic prodecures or in human.
Hot Tags: recombinant human bcma/tnfrsf17 #abs00860, China recombinant human bcma/tnfrsf17 #abs00860 suppliers
Send Inquiry
You Might Also Like






